HOME >> MEDICINE >> NEWS
Insulin sensitizer has anti-inflammatory effect in diabetics

SAN FRANCISCO -- A drug used widely as an insulin sensitizer appears also to have a significant anti-inflammatory effect in diabetics, a property that could make it useful in helping to prevent heart disease in these patients, a study by endocrinologists at the University at Buffalo has found.

Results of the research, involving the drug rosiglitazone, were presented here today (June 15, 2002) at the annual meeting of the American Diabetes Association. Rosiglitazone is sold under the brand name Avandia(r).

UB endocrinologists, led by Paresh Dandona, M.D., professor of medicine and head of the Division of Endocrinology in the UB School of Medicine and Biomedical Sciences, have been studying the anti-inflammatory properties of insulin and insulin sensitizers and their potential use in treatment and prevention of atherosclerosis, one of the leading causes of heart attacks.

Atherosclerosis, or hardening of the arteries, begins as an inflammation of the blood-vessel wall. Persons with diabetes are at increased risk of developing atherosclerosis and heart disease. Dandona's lab has shown in research with a small group of obese non-diabetic volunteers that rosiglitazone decreased the levels of oxygen free radicals which can begin the inflammation cascade by injuring blood-vessel linings. The drug also decreased the levels of several blood markers of inflammation.

The current study involved 11 obese patients with Type 2 diabetes. In this disease, also referred to as adult-onset diabetes, the body produces adequate amounts of insulin, but cells don't respond to its action. Rosiglitazone is prescribed to break down this resistance to insulin.

Researchers collected blood samples from the diabetic volunteers and started them on a six-week course of daily rosiglitazone. They repeated the blood sampling four times during the six weeks of treatment and again at 12 weeks, and analyzed the samples for concentration of three inflammatory markers and fo
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
15-Jun-2002


Page: 1 2

Related medicine news :

1. Insulin resistance intervention after stroke focus of $33 million grant
2. Audio conference: Insulin resistance and polycystic ovary syndrome
3. Insulin pumps effective for children with diabetes
4. Insulin pump benefits preschoolers with diabetes
5. Insulin decreases inflammation, aids clot-busting drugs in heart attack patients, UB study shows
6. Insulin-producing cells found in a variety of tissues in diabetes
7. Insulin pump effective for infants, children
8. Insulin precursor linked with increased stroke risk; may represent new risk factor
9. Compound That Mimics Insulin Might Lead To Pill For Diabetes, As Reported In The 7 May Issue Of Science
10. Insulin Resistance And Obesity Avoided In Genetically Modified Mice, As Reported In Science
11. Encapsulating Insulin-Producing Cells For Possible Diabetes Therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2020)... (PRWEB) , ... May 30, 2020 , ... ... advanced technology and virtual solutions that can meet the needs of a COVID-riddled ... HashCash’s healthcare solutions abide by the necessary compliances and augment the ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... is now manufacturing face shields to be used as personal protective equipment ... These face shields are single use, made to be worn by frontline healthcare ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... which certain infections can impact the brain causing post infectious encephalitis. The ... with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) could adversely attack ...
(Date:5/26/2020)... YORK (PRWEB) , ... May 26, 2020 , ... ... to the coronavirus pandemic, medical centers across the United States are joining forces ... health care workers who have worked tirelessly to save lives. #FitForTheFrontLine is a ...
(Date:5/21/2020)... , ... May 21, 2020 , ... ... manufacturer, announces its first milestone to deliver over one million FDA-compliant face shields ... Summit Medical Face Shields meet the critical need for personal protective equipment (PPE) ...
Breaking Medicine News(10 mins):
(Date:5/28/2020)... SPRINGS, Colo. (PRWEB) , ... May 28, 2020 ... ... reduce the time to select the desired recipients. , “Notify.com is an acknowledgement-based ... every message sent to users—whether it be a PUSH notification, SMS text message, ...
(Date:5/27/2020)... ... May 27, 2020 , ... Focus Technology , a leading provider of ... will once again sponsor the American Heart Association’s 2020 Boston Heart Walk, ... third year the firm is sponsoring the AHA event. The sponsorship donation will be ...
(Date:5/26/2020)... ... May 26, 2020 , ... SignatureCare Emergency Center, your friendly ... TX . , The new ER is set to open early June, 2020, and ... at 21315 N SH 130, Bldg.4, Pflugerville, TX. , According to Dr. Aaron ...
Breaking Medicine Technology:
Cached News: